The

Spanish Agency for Medicines and Health Products

(

AEMPS

), dependent on the

Ministry of Health

, has withdrawn several batches of presentations of the drugs

Diosmina

and

Flebicorn

, both from the company

Kern Pharma

, due to the "detection of an impurity above its limit settled down".

Both are

venotonic drugs

, that is, they increase the tone of the veins and the resistance of the capillaries (small blood vessels).

You can check here the lots withdrawn.

In adults, they are indicated for the relief of symptoms related to mild venous insufficiency of the lower extremities, such as pain, a sensation of heaviness, tightness, tingling and itching in legs with varicose veins or swollen legs.

Given the detection of the impurity, Health has decided to withdraw from the market all the units distributed from the affected batches and return them to the laboratory through the usual channels.

Conforms to The Trust Project criteria

Know more

HealthPatients with previous corticosteroid treatment hospitalized with Covid have a worse prognosis

Coronavirus The WHO warns that the endemic is not the solution to Covid: "It only means that it will be here forever"

Health The rate of deaths from Covid is up to 48 times lower with the third dose than without the vaccine

See links of interest

  • Last News

  • covid

  • Ukraine

  • Work calendar 2022

  • The reading

  • esther lopez

  • Athletic Club - Espanyol